Influence of a recombinant hemoglobin solution on blood rheology

Transfusion

Volumn 37, Issue 11-12, 1997, Pages 1149-1155

  Stetter, M N ^a   Baerlocher, G M ^a   Meiselman, H J ^b   Reinhart, W H ^c  

^a Kantonsspital ^*

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KANTONSSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HETASTARCH; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; BLOOD RHEOLOGY; BLOOD TRANSFUSION; BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEMODILUTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; OXYGEN TRANSPORT; VIRUS INFECTION;

EID: 0031447014     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37111298088044.x     Document Type: Article

References (40)

1. Sloand EM, Pitt E, Klein HG. Safety of the blood supply. JAMA 1995;274:1368-73.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
3. Berbers GA, Bleeker WK, Stekkinger P, et al. Biophysical characteristics of hemoglobin intramolecularly cross-linked and polymerized. J Lab Clin Med 1991;117:157-65.
4. Fricker J. Artificial blood-bad news for vampires? (news) Lancet 1996;347:1322.
5. Ogden JE. Recombinant haemoglobin in the development of red-blood-cell substitutes. Trends Biotechnol 1992;10:91-6.
6. Heneka MT, Loschmann PA, Osswald H. Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat. J Clin Invest 1997;99:47-54.
7. Moss GS, Gould SA, Sehgal LR, et al. Hemoglobin solution - from tetramer to polymer. Surgery 1984;95:249-55.
8. Bowes MP, Burhop KE, Zivin JA. Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits. Stroke 1994;25:2253-7.
9. Hughes GS Jr, Yancey EP, Albrecht R, et al. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharmacol Ther 1995;58:434-43.
10. Hoffman SJ, Looker DL, Roehrich JM, et al. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc Natl Acad Sci U S A 1990;87:8521-5.
11. Wagenbach M, O'Rourke K, Vitez L, et al. Synthesis of wild type and mutant human hemoglobins in Saccharomyces cerevisiae. Biotechnology (NY) 1991;9:57-61.
12. Ackers GH, Halvorson HR. The linkage between oxygenation and subunit dissociation in human hemoglobin. Proc Natl Acad Sci U S A 1974;71:4312-6.
13. Bunn HF, Esham WT, Bull RW. The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 1969;129:909-23.
14. Bunn HF, Esham WT, Bull RW. The renal handling of hemoglobin. II. Catabolism. J Exp Med 1969;129:925-34.
15. Looker D, Abbott-Brown D, Cozart P, et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992;356:258-60.
16. Viele MK, Weiskopf RB, Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 1997;86:848-58.
17. Loeb AL, McIntosh LJ, Raj NR, Longnecker DE. The systemic and regional hemodynamic response to hemorrhage is improved by the recombinant human hemoglobin (Optro™, rHb 1.1). Int J Microcirc 1996;16(Suppl 1):185.
18. Schmid-Schonbein H, Volger E, Klose HJ. Microrheology and light transmission of blood. The photometric quantification of red cell aggregate formation and dispersion in flow. Pflugers Arch 1972;333:140-55.
19. Bauersachs RM, Wenby RB, Meiselman HJ. Determination of specific red blood cell aggregation indices via an automated system. Clin Hemorheol 1989;9:1-25.
20. Koutsouris D, Guillet R, Wenby RB, Meiselman HJ. Determination of erythrocyte transit times through micropores. II. Influence of experimental and physicochemical factors. Biorheology 1989;25:881-98.
21. Fisher TC, Wenby RB, Meiselman HJ. Pulse shape analysis of RBC micropore flow via new software for the cell transit analyser (CTA). Biorheology 1992;29:185-201.
22. Moessmer G, Meiselman HJ. A new micropore filtration approach to the analysis of white cell rheology. Biorheology 1990;27:829-48.
23. Pecsvarady Z, Fisher TC, Fabok A, et al. Kinetics of granulocyte deformability following exposure to chemotactic stimuli. Blood Cells 1992;18:333-52; discussion 353-8.
24. Reinhart WH, Nagy C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 1995;25:523-8.
25. Yamauchi H, Fukuyama H, Ogawa M, et al. Hemodilution improves cerebral hemodynamics in internal carotid artery occlusion. Stroke 1993;24:1885-90.
26. Hiippala S, Linko K, Myllyla G, et al. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiol Scand 1995;39:228-35.
27. Beards SC, Watt T, Edwards JD, et al. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomised trial. Crit Care Med 1994;22:600-5.
28. Mortelmans YJ, Vermaut G, Verbruggen AM, et al. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg 1995;81:1235-42.
29. Vollmar B, Lang G, Menger MD, Messmer K. Hypertonic hydroxyethyl starch restores hepatic microvascular perfusion in hemorrhagic shock. Am J Physiol 1994;266:H1927-34.
30. Mastroianni L, Low HB, Rollman J, et al. A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol 1994;34:34-40.
31. Chien S. Rheology in the microcirculation in normal and low flow states. Adv Shock Res 1982;8:71-80.
32. Meiselman HJ. Red blood cell role in RBC aggregation. Clin Hemorheol 1993;13:575-92.
33. Betticher DC, Keller HU, Maly FE, Reinhart WH. The effect of endotoxin and tumour necrosis factor on erythrocyte and leucocyte deformability in vitro. Br J Haematol 1993;83:130-7.
34. Frank RS. Time-dependent alterations in the deformability of human neutrophils in response to chemotactic activation. Blood 1990;76:2606-12.
35. Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Scandinavian Stroke Study Group. Stroke 1987;18:691-9.
36. Grotta JC. Can raising cerebral blood flow improve outcome after acute cerebral infarction? Stroke 1987;18:264-7.
37. Haemodilution in acute stroke: results of the Italian haemodilution trial. Italian Acute Stroke Study Group. Lancet 1988;1:318-21.
38. Marcus AJ, Broekman MJ. Cell-free hemoglobin as an oxygen carrier removes nitric oxide, resulting in defective thromboregulation (editorial; comment). Circulation 1996;93:208-9.
39. Matheson-Urbaitis B, Lu YS, Fronticelli C, Bucci E. Renal and systemic-hemodynamic response to isovolemic exchange transfusion with hemoglobin cross-linked with bis (3.5-dibromosalicyl) fumarate or albumin. J Lab Clin Med 1995;126:250-60.
40. Olsen SB, Tang DB, Jackson MR, et al. Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation 1996;93:327-32.